
Carl Zeiss Meditec AG
CZMWY
Updated: 24/09/2026, 18:14:52
Carl Zeiss Meditec AG functions as a prominent global medical technology firm, conducting its operations across Germany, other European nations, the United States, and various Asian markets. Its business is organized into two principal divisions: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment provides an array of products and solutions tailored for the diagnosis and therapeutic management of ocular conditions, including specialized systems and essential consumables for cataract, retinal, and refractive surgical procedures. This division serves ophthalmologists, optometrists, and medical and surgical professionals in hospitals and ambulatory surgery centers. The Microsurgery segment focuses on delivering advanced visualization tools vital for intricate surgical interventions, additionally supplying specialized solutions for ear, nose, and throat (ENT), plastic and reconstructive, dental, and spinal surgeries. This segment supports a diverse group of medical practitioners across various disciplines, as well as healthcare institutions. Established in 1846 and headquartered in Jena, Germany, the company operates as a subsidiary of Carl Zeiss AG.
No summaries found.
- Share price
- $35.70
- Market cap
- $3.13B
- Exchange
- OTC
- Currency
- USD
- CEO
- Andreas Pecher
- Employees
- 5,784
- IPO date
- 03/08/2012
- Beta
- 1.467
- Last dividend
- $0.00
- Day range
- $35.57 – $35.72
- 52-week range
- $26.65 – $55.94
- 1-day performance
- 2.65%
- 1-year performance
- 33.96%
- Current drawdown (1Y)
- -36.18%
- CIK
- N/A
- CUSIP
- 14218T105
- ISIN
- US14218T1051
- Created
- 07/12/2025, 03:32:13
- Last update
- 24/09/2026, 18:14:52
Track Carl Zeiss Meditec AG with an AI analyst
See which prediction-market events move CZMWY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.